Tepha, Inc - CeMBR<

Parents

Cambridge, Massachusetts 02142
Development stage medical device company engaged in utilizing unique and proprietary biomaterials derived from a class of polyme
Earlier rounds include a $4.3 million venture capital funding in 2004 and a $10.7 million financing in 2007.
Forty investors, unnamed in the filing, participated in the latest funding.
Founded 1989
Funding Round Nets $11.3 Million for Absorbable Material (2012)
In February 2010, Tepha also pulled a $3 million funding.
Its TephaFLEX polymer has been used in FDA-approved surgical suture and surgical meshes.
Makes absorbable biomaterials that the company says adds flexibility, elasticity and biocompatibility to medical device products.
Spinoff of a collaboration between its sister company Metabolix Inc. in Cambridge and Children’s Hospital Boston to develop technologies related to cardiac tissue engineering.
Tepha investors in its Series A and Series B round of financings included The Vertical Group, Novartis Venture Fund, Integra Ventures, Westfield Life Sciences Fund “and others.”
Tepha pulls in $5M funding for absorbable medical devices